China Cancer Screening Market Status, Key Trends, Growth Factors, Value Chain and Key Players
China’s demand for cancer screening has grown at a fast pace in the past decade. Cancer is one of the most significant healthcare burdens in China. The Chinese economy maintains a high pace of growth stimulated by the consecutive increase in capital investment. The cancer screening market in China is expected to reach USD 1.5 Bn by 2023 at 14 % CAGR. The cancer screening market in China is classified by end users, screening type and applications. By end users, it is further classified into hospitals, laboratories and independent physicians and clinics. By screening type it is classified into laboratory, genetic, biopsy, imaging and endoscopy testing. By application type, it is further classified into lung, breast, melanoma, kidney and colorectal cancer. Request for Sample @ https://www.kdmarketinsights.com/sample/3280 Key growth factors Rise in the population along with an increase in the patient pool and favourable government policies is a key driver for t...